UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057488
Receipt number R000065690
Scientific Title Accurate imaging diagnosis of early pancreatic cancer using combined indirect imaging findings
Date of disclosure of the study information 2025/04/02
Last modified on 2025/04/02 13:35:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Accurate imaging diagnosis of early pancreatic cancer using combined indirect imaging findings

Acronym

Accurate imaging diagnosis of early pancreatic cancer using combined indirect imaging findings

Scientific Title

Accurate imaging diagnosis of early pancreatic cancer using combined indirect imaging findings

Scientific Title:Acronym

Accurate imaging diagnosis of early pancreatic cancer using combined indirect imaging findings

Region

Japan


Condition

Condition

early pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether the combination of indirect imaging findings improves the diagnostic performance for early pancreatic cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary endpoint was to evaluate the diagnostic performance of characteristic indirect imaging findings, with a particular focus on the diagnostic value of combined indirect imaging findings of malignant lesions.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Between May 2015 and February 2024, ERP examinations performed to diagnose suspected EPC based on irregular MPD calibers.

Key exclusion criteria

Patients were excluded if they had a follow-up period of < 5 years without surgical resection, were lost to follow-up, lacked imaging data (CT/MRI/ERP), had multiple stenoses due to chronic pancreatitis, or had histologically confirmed PC with a diameter > 10 mm. In addition, PC originating from branch duct intraductal papillary mucinous neoplasms was naturally excluded.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Ryota
Middle name
Last name Sagami

Organization

Faculty of Medicine, Oita University

Division name

Department of Gastroenterology/Department of Advanced Gastrointestinal Cancer Medicine

Zip code

8795593

Address

1-1 Idaigaoka, hasama-cho, Yufu, Oita, 8795593, Japan

TEL

+81-97-549-4411

Email

sagami1985@yahoo.co.jp


Public contact

Name of contact person

1st name Ryota
Middle name
Last name Sagami

Organization

Faculty of Medicine, Oita University

Division name

Department of Gastroenterology/Department of Advanced Gastrointestinal Cancer Medicine

Zip code

8795593

Address

1-1 Idaigaoka, hasama-cho, Yufu, Oita, 8795593, Japan

TEL

+81-97-549-4411

Homepage URL


Email

sagami1985@yahoo.co.jp


Sponsor or person

Institute

Oita University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Medicine, Oita University

Address

1-1 Idaigaoka, hasama-cho, Yufu, Oita, 8795593, Japan

Tel

+81-97-549-4411

Email

sagami1985@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 06 Month 06 Day

Date of IRB

2024 Year 11 Month 21 Day

Anticipated trial start date

2025 Year 04 Month 02 Day

Last follow-up date

2029 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 04 Month 02 Day

Last modified on

2025 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065690